Being able to prove chain of title for patent ownership is vital, but doesn't have to be complicated. Read Lucy's LinkedIn article that maps out the links in the chain for small entitles and multinationals, and contains advice on choice of assignment language and signatories (and even flags some tax pitfalls!).

Lucy was recently interviewed for The Royal Society of Chemistry's magazine "Chemistry World" about her career in IP. Click here to read the article.

Ask any patent practitioner the hardest territories in which to pursue pharmaceutical patents and they will probably mention Brazil. Idiosyncrasies in the way Brazil examines patent applications have caused huge delays in prosecution, as well as complaints of unfair rejections and even bias against foreign applicants.

The NY Times recently covered a fascinating deal between the pharmaceutical company Allergan and the Saint Regis Mohawk Tribe, a Native American tribe from New York.

Michael Caine from Davis Collison Cave Pty Ltd recently carried out a study to identify the various national requirements for the effective transfer of priority rights in accordance with Article 4A(1) of the Paris Convention. The study focused on the manner in which various countries and regions have implemented the provisions of Article 4A(1) and resulted in some useful guidelines.